Navigation Links
Emerging Growth Equities, Ltd. Initiates Coverage of PolyMedix Inc. With a Buy Rating and a $9.00 Price Target
Date:12/11/2008

KING OF PRUSSIA, Pa., Dec. 11 /PRNewswire/ -- Emerging Growth Equities, Ltd. initiates coverage of PolyMedix Inc. (OTC Bulletin Board: PYMX) with a BUY rating and a $9.00 price target. PolyMedix focuses on developing novel high-value therapeutic drug products for serious, life-threatening acute disorders. The Company's leading clinical development programs include the antibiotic PMX-30063 and the heparin antagonist PMX-60056.

Emerging Growth Equities, Ltd., is a specialty brokerage and investment banking firm that provides distribution, research and trade execution, primarily for institutional clients. Emerging Growth Equities, Ltd. specializes in fulfilling the capital requirements of well-managed emerging growth companies.

Institutional investors may call their Emerging Growth Equities, Ltd. sales person for a full text of the report.

This publication is neither an offer to sell nor a solicitation to buy any securities mentioned herein. The information contained herein is based on data obtained from recognized sources that are believed to be reliable. Emerging Growth Equities, Ltd. has not independently verified the facts, assumptions and estimates contained in this report. Accordingly, no representation or warranty, expressed or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information and opinions contained in this report. The information contained in this report is not and does not purport to be a complete analysis of every material fact respecting any company, industry, or security.

Most of the companies Emerging Growth Equities, Ltd. follows are emerging and mid-sized growth companies whose securities typically involve a higher degree of risk and more volatility than the securities of more established companies. For these and other reasons, the investments discussed or recommended
'/>"/>

SOURCE Emerging Growth Equities, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Computers help chemists fight emerging infections
2. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
3. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
4. GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology
5. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
6. HealthShares(TM) Announces Change to the HealthShares(TM) Emerging Cancer Index
7. Targets on the horizon: Emerging therapies and novel targets
8. Emerging therapies with a focus on Asian populations mark the AACR Centennial Conference
9. Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy
10. OneMedPlace Emerging Healthcare Technologies Finance Forum Jan 7, 8th
11. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 Motion Graphics ... of a new plugin FCPX3D Confetti designed exclusively for ... exploding transition using confetti particles inside FCPX,” said Christina ... FCPX3D Confetti transition, users will have fun as they ... from one clip to the next with 3D tumbling ...
(Date:3/2/2015)... 02, 2015 Getting customers to discover ... the goal this March as the 31st annual Frozen ... the National Frozen & Refrigerated Foods Association (NFRA) to ... offers more than 20 delicious frozen selections and is ... The tasty frozen options are crafted with simple ingredients, ...
(Date:3/2/2015)... 02, 2015 Cutler Integrative Medicine a ... the root, gives cutting-edge tips to bring about self-renewal. ... renew the body by first cleaning house. According ... “We are all Toxic.” Between environmental toxins like heavy ... greatness, and our high stress levels, we all have ...
(Date:3/2/2015)... York, NY (PRWEB) March 02, 2015 ... long history of catalyzing private sector activities and ... it has recently elected four new members to ... GBCHealth welcomes Dr. Paul Farmer, Chief Strategist and ... Professor at Harvard University; Dr. Huma Abbasi, General ...
(Date:3/2/2015)... NY (PRWEB) March 02, 2015 ... Administration (FDA) warned against the use of power ... and fibroid removal surgeries, insurer UnitedHealthCare is poised ... use of those devices. In a notification sent ... beginning in April, it would require pre-authorization for ...
Breaking Medicine News(10 mins):Health News:A new Confetti Generator entitled FCPX3D Confetti was released today from Pixel Film Studios for Final Cut Pro X 2Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4
... , The Authority offers patients consumer tips and encourages ... improved patient safety , , HARRISBURG, ... Patient Safety Day," Saturday, July 25, which is a national effort ... in their healthcare. , , Pulse ...
... ANAHEIM, Calif., July 24 Elekta CMS Software has ... an advanced IMRT treatment planning solution that combines new levels ... , Monaco with VMAT can optimize ... control needed for complex treatment plans. Reducing planning time and ...
... can be tough, experts admit , FRIDAY, July 24 (HealthDay News) ... not be catching enough zzzs. , Getting a good night,s sleep, ... for shedding baby weight. , One study of new mothers found ... months after giving birth were three times as likely to hold ...
... , DUBLIN, Ohio, July 24 Cardinal ... information officer (CIO), effective Aug. 3. , ... company,s enterprise-wide information technology infrastructure and will work to enhance ... will report to George Barrett, who will become chairman and ...
... , CHICAGO, July 24 International ... designing and manufacturing portable rechargeable systems, today launched ... power supplies. The new 350-watt series, designed for ... an industry-leading converter efficiency of up to 88%. ...
... ... of investment with GBS Venture Partners as AP prepares for market launch of its Navigator™ ... Sydney, ... Pty Ltd (AP), a developer of circulation guidance systems for critically-ill patients, announced today ...
Cached Medicine News:Health News:Pennsylvania Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Pennsylvania Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution 2Health News:Snoozing May Help Women Shed Baby Weight 2Health News:Snoozing May Help Women Shed Baby Weight 3Health News:Cardinal Health Names Patricia Morrison Chief Information Officer 2Health News:Convection Cooled 350-Watt Open Frame Power Supply Meets Medical and Industrial Safety Standards 2Health News:Applied Physiology Raises $5 Million for Navigator™ Market Launch 2Health News:Applied Physiology Raises $5 Million for Navigator™ Market Launch 3
(Date:3/2/2015)...  IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey ... the fourth quarter and year ended December 31, 2014. ... , Total revenues of $13.7 million in the fourth ... quarter in 2013 , Total revenues of $33.7 million ... 85% over the same period in 2013 , Total ...
(Date:3/2/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... year ended December 31, 2014. Financial highlights for the fourth ... of $5.3 million, or $0.04 per share. This compares to ... million, or $0.19 per share, for the fourth quarter of ... of $75.3 million and a net loss of $68.4 million, ...
(Date:3/2/2015)... , March 2, 2015   Polymedco is committed to ...  During CRC Awareness Month, we are offering all existing ... , Posters – to be hung in ... CRC Patient Brochures with Stand – to be placed ... – to be put on/in patient charts as a ...
Breaking Medicine Technology:IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2
... Genprex, Inc. announced today that it will be presenting at ... San Francisco.   Greg Heinlein , Chief Operating and Financial Officer, ... Forum , on October 25 starting at 11 a.m. PDT in ... be made available on the company,s website under the News & ...
... CINCINNATI, Oct. 20, 2011 Prasco Laboratories , announced ... Eli Lilly and Company (NYSE: LLY ... Tablets and ZYPREXA® ZYDIS (olanzapine) Orally Disintegrating Tablets, in the ... products upon the first ANDA entrant into the market.  Prasco ...
Cached Medicine Technology:Genprex Presenting at 10th Annual BIO Investor Forum 2Prasco® Selected as Eli Lilly and Company's Authorized Generics Partner 2
ROC XS is a polyethylene implant used for soft tissue reattachment to bone. The umbrella-like deployment of this anchor provides increased fixation strength. This anchor is easy-to-insert using the R...
... The Rotator Cuff Anchor (RCA), ... for soft tissue reattachment to bone. ... which eliminates the need to predrill ... in fixation is due to subcortical ...
... The Linvatec 5mm Super Revo Suture ... for arthroscopic or a mini-open rotator cuff ... and the anchor is pre-threaded with two ... potential pitfalls of suture management are avoided ...
... the standard measurement procedure to ... operations in just one step. ... Start button, the R-F10 automatically ... steps for both eyes: alignment, ...
Medicine Products: